Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX

Wellington Management Group LLP reported a 7.50% stake in Crinetics Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 10, 2025

Wellington Management Group LLP reported a 7.50% stake in Crinetics Pharmaceuticals, Inc., 6,950,567 shares, as a passive investor on Dec 31, 2024. Filed Feb 10, 2025 (Schedule 13G/A).

Stake
7.50%
Shares
6,950,567
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Wellington Management Group LLP7.50%6,950,567
Wellington Group Holdings LLP7.50%6,950,567
Wellington Investment Advisors Holdings LLP7.50%6,950,567
Wellington Management Company LLP7.10%6,950,567

Source

View original at SEC

Related